-+ 0.00%
-+ 0.00%
-+ 0.00%

Xeris Biopharma Names Menassie M. Taddese Independent Director

PUBT·11/05/2026 12:10:54
Listen to the news
Xeris Biopharma Names Menassie M. Taddese Independent Director
  • Xeris Biopharma appointed Menassie M. Taddese as an independent director, effective November 2, 2026.
  • Taddese has nearly 30 years of global biopharmaceutical leadership experience spanning commercial operations, corporate finance and broader corporate leadership.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611050700BIZWIRE_USPR_____20261105_BW731893) on November 05, 2026, and is solely responsible for the information contained therein.